Meril Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 59.36 Cr
as on 08-07-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 565.61 Cr
as on 08-07-2024
- Satisfied Charges ₹ 207.60 Cr
as on 08-07-2024
- Revenue 33.10%
(FY 2022)
- Profit 236.10%
(FY 2022)
- Ebitda 59.89%
(FY 2022)
- Net Worth 20.83%
(FY 2022)
- Total Assets 9.50%
(FY 2022)
About Meril Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 59.36 Cr.
The company currently has active open charges totaling ₹565.61 Cr. The company has closed loans amounting to ₹207.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Meril Life Sciences Private Limited India is Rushi Sathe as COMPANY SECRETARY. Nanubhai Bambharolia, Rajnikant Vyas, and Hemchandra Panjikar serve as directors at the Company.
- CIN/LLPIN
U24239GJ2007PTC051137
- Company No.
051137
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2007
- Date of AGM
09 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Meril Life Sciences Private Limited offer?
Meril Life Sciences Private Limited offers a wide range of products and services, including Pathology Lab Equipments, Microplate Reader, IVDs & Analyzers, Hematology Analyzers, Forceps & Graspers, Surgical Equipments, Scalpels, Needles & Scissors, Non Absorbable Sutures, Medical Consultants & Clinics, Medical Consultancy Services.
Who are the key members and board of directors at Meril Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rushi Sathe | Company Secretary | 01-Jun-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nanubhai Bambharolia  | Whole-Time Director | 19-Jun-2007 | Current |
| Rajnikant Vyas | Whole-Time Director | 14-Sep-2007 | Current |
| Hemchandra Panjikar | Director | 11-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Meril Life Sciences.
Meril Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.1% increase. The company also saw a substantial improvement in profitability, with a 236.1% increase in profit. The company's net worth Soared by an impressive increase of 20.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meril Life Sciences?
In 2022, Meril Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Meril Endo Surgery Private LimitedActive 13 years 7 monthsRajnikant Vyas and Hemchandra Panjikar are mutual person
- Milestone Holdings & Infrastructure Private LimitedActive 39 years 2 months
Nanubhai Bambharolia is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Jun 2023 | ₹146.00 Cr | Open |
Others Creation Date: 28 Sep 2021 | ₹110.00 Cr | Open |
Others Creation Date: 24 May 2021 | ₹21.16 Cr | Open |
How Many Employees Work at Meril Life Sciences?
Meril Life Sciences has a workforce of 1453 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meril Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meril Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
